This application addresses the Funding Opportunity: PAR-13-187 Reducing the Duration of Untreated Psychosis in the United States (R01) Project Title: STEP-ED: Reducing Duration of Untreated Psychosis and its impact in the U.S. The guiding questions for this study are whether a U.S. adaptation of a successful early detection approach undertaken in Norway (TIPS) can substantially reduce the duration of untreated psychosis (DUP) and improve outcomes beyond existing specialty first-episode services (FES) in a policy-relevant U.S. setting. The proposed study involves a quasi-experimental design wherein one site that delivers FES (STEP, New Haven) will add an Early Detection (ED) campaign to reduce DUP in its catchment area, while a control site (PREP, Boston) will continue to deliver equivalent FES without ED. We hypothesize that DUP will be reduced significantly in the early detection site compared to the usual detection site. Also, we hypothesize that this reduction in DUP will translate into improvements 1 year outcomes at the ED site compared to the non-ED site, demonstrating the 'added value'of ED to already established and effective FES. The primary outcome of DUP will be measured in a consistent manner at both sites using the Symptom Onset Scale, which is comprehensive in assessing early symptoms, reliable and has been used by both sites for e5 years. 1 year outcomes will be measured at both sites and will assess three broad domains: 1) clinical status: including hospitalization rate and relapse, suicidality, aggression and symptom scales;2) functional status: including ability to work or attend age- appropriate schooling, social functioning and quality of life and 3) costs: broadly measured to include costs of treatment and social and forensic services used. The Early Detection campaign will include a social marketing component targeting patients and families to increase help-seeking behavior, professional outreach to improve the rapidity of referral to STEP from local agencies and operationalizing rapid responsiveness of the STEP clinic to referrals, all with the aim of minimizing DUP. Analysis for DUP will be centered on the primary outcome of the proportion arriving to each FES with a DUPd3months. Analysis for 1-year outcomes will be centered on proportions who are vocationally engaged at each site.

Public Health Relevance

Psychotic illnesses are severely disabling and costly under usual care in the U.S. The provision of treatment that is effective and delivered early after psychosis onset has the potential to improve long-term outcomes. The Specialized Treatment Early in Psychosis and Early Detection (STEP-ED) project is designed to test addition of an early detection campaign to an existing, comprehensive and effective service (STEP) to shorten the time between psychosis onset and effective treatment and has the potential to significantly improve the long term outcomes of psychotic illnesses in the U.S.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH103831-02
Application #
8743300
Study Section
Special Emphasis Panel (ZMH1)
Program Officer
Azrin, Susan
Project Start
2013-09-26
Project End
2018-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06510
Foss-Feig, Jennifer H; Adkinson, Brendan D; Ji, Jie Lisa et al. (2017) Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders. Biol Psychiatry 81:848-861
Srihari, Vinod H; Jani, Anant; Gray, Muir (2016) Early Intervention for Psychotic Disorders: Building Population Health Systems. JAMA Psychiatry 73:101-2
Guloksuz, Sinan; Li, Fangyong; Tek, Cenk et al. (2016) Analyzing the Duration of Untreated Psychosis: Quantile Regression. JAMA Psychiatry 73:1094-1095
Tek, Cenk; Kucukgoncu, Suat; Guloksuz, Sinan et al. (2016) Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications. Early Interv Psychiatry 10:193-202
van Schalkwyk, Gerrit Ian; Davidson, Larry; Srihari, Vinod (2015) Too Late and Too Little: Narratives of Treatment Disconnect in Early Psychosis. Psychiatr Q 86:521-32
Annamalai, Aniyizhai; Palmese, Laura B; Chwastiak, Lydia A et al. (2015) High rates of obstructive sleep apnea symptoms among patients with schizophrenia. Psychosomatics 56:59-66
Hay, Rachel A; Roach, Brian J; Srihari, Vinod H et al. (2015) Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biol Psychol 105:130-7
Gray, Bradley E; McMahon, Robert P; Green, Michael F et al. (2014) Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophr Res 159:182-7
Perez, Veronica B; Woods, Scott W; Roach, Brian J et al. (2014) Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. Biol Psychiatry 75:459-69
Srihari, Vinod H; Tek, Cenk; Pollard, Jessica et al. (2014) Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study. BMC Psychiatry 14:335

Showing the most recent 10 out of 13 publications